Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-11.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Acute Symptoms after a Community Hydrogen Fluoride Spill
Skip Navigation
Skip to contents

Ann Occup Environ Med : Annals of Occupational and Environmental Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Ann Occup Environ Med > Volume 25; 2013 > Article
Research Article Acute Symptoms after a Community Hydrogen Fluoride Spill
Joo-Yong Na1, Kuck-Hyun Woo1, Seong-Yong Yoon1, Seong-Yong Cho1, In-Ung Song1, Joo-An Kim1, Jin-Seok Kim1
Annals of Occupational and Environmental Medicine 2013;25:17-17.
DOI: https://doi.org/10.1186/2052-4374-25-17
Published online: September 19, 2013

1Department of Occupational and Environmental Medicine, Soonchunhyang University Gumi Hospital, 179, Gongdan 1-dong, Gumi-si, Gyeongbuk 730-706, Korea

• Received: April 16, 2013   • Accepted: August 1, 2013

Copyright © 2013 Na et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 201 Views
  • 0 Download
  • 21 Web of Science
  • 25 Crossref
prev next
  • Objectives
    This study was conducted to describe the demographic characteristics, and clinical signs and symptoms of patients who visited a general hospital because of the release of chemically hazardous hydrogen fluoride that occurred on September 27, 2012 in Gumi City, Korea.
  • Methods
    The medical records at 1 general hospital 9 km from the accident site were reviewed using a standardized survey format. There were 1,890 non-hospitalized and 12 hospitalized patients exposed to hydrogen fluoride between September 27 and October 13 2012.
  • Results
    Among the 12 hospitalized patients, 11 were discharged within 1 week and the other was hospitalized for 10 days. The chief complaints were respiratory symptoms such as hemoptysis and shortness of breath, gastrointestinal symptoms, neurologic symptoms, sore throat, and lip burn.
    The number of non-hospitalized patients exhibited a bimodal distribution, peaking on the first and twelfth days after the accident. Their chief complaints were sore throat (24.1%), headache (19.1%), cough (13.1%), and eye irritation (9.2%); some patients were asymptomatic (6.2%). Patients who visited the hospital within 3 days (early patients) of the spill more often had shortness of breath (27.0%) and nausea (6.3%) as the chief complaints than patients who visited after 3 days (late patients) (3.5% and 2.6%, respectively). However, cough and rhinorrhea were more common in the late patients (14.0% and 3.3%, respectively) than in the early patients (5.0% and 0.0%, respectively). Patients who were closer to the accident site more often had shortness of breath and sputum as the chief complaints than patients who were farther away. The mean serum calcium concentration was 9.37 mg/dL (range: 8.4–11.0 mg/dL); none of the patients had a decreased serum calcium level. Among 48 pulmonary function test results, 4 showed decreased lung function. None of the patients had abnormal urine fluoride levels on the eighth day after exposure.
  • Conclusions
    Patients hospitalized due to chemical hazard release of hydrogen fluoride had acute respiratory, gastrointestinal, and neurologic health problems. Non-hospitalized patients have acute symptoms mainly related to upper respiratory irritation.
Hydrogen fluoride is a highly hydrophilic and corrosive irritant that may cause burns to the skin and eyes and may damage the upper respiratory tract and lungs when inhaled. Hydrogen fluoride and its aqueous solution, hydrofluoric acid, can infiltrate the body via all exposure routes. It is less acidic than inorganic acids such as hydrogen chloride and hydrogen sulfide. However, its high permeability can be fatal and cause deep tissue damage after a certain period of time from the initial contact with skin [1-6]. The most representative chronic toxicities of hydrogen fluoride are osteofluorosis and dental fluorosis, which involve the deposition of fluoride in the bones and teeth in people constantly consuming fluoride-contaminated drinking water or in workers performing aluminum smelting who are chronically exposed to hydrogen fluoride [7,8]. Hydrogen fluoride has been used in glasswork since the 17th century and is currently used in the manufacturing of high-octane gasoline for aviation fuel, metal plating, and high-temperature surface processing as well as in the production of plastics and refrigerants. In particular, hydrogen fluoride is capable of etching glass and metals, which prompts its widespread use in the semiconductor industry and in the manufacturing of electronic displays [1,9].
On September 27, 2012 at 3:40 pm, a hydrogen fluoride spill occurred in a hydrogen fluoride manufacturing plant located in Gumi City while 100% hydrogen fluoride (anhydrous hydrofluoric acid) was being transferred from a hydrogen fluoride tanker truck to a storage tank. An estimated 8–12 tons of hydrogen fluoride was leaked over approximately 8 h until the tank spill was completely stopped. This accident killed 5 workers on site and hydrogen fluoride spread through the air, damaging the health of local residents and industrial workers as well as crops and other facilities [10].
The accident site was located at the fourth complex of the Gumi National Industrial Complex; local residents lived within a 2 km radius (Figure 1). According to the Gumi municipal accident report, the estimated time of the accident was 3:40 pm. The first evacuation notice was issued to the residents living within a 1.5 km radius around 4:50 pm, followed by an evacuation order for all residents living within a 1.3 km radius at 8:20 pm. According to the report of the Gumi Municipal Government [10], the atmospheric hydrogen fluoride concentration at the accident site was first measured 8 h after the accident and was 1 ppm. However, the second measurement, which was conducted at the accident site 5 h later, did not detect hydrogen fluoride in the atmosphere or nearby residential areas. The results of the initial water and soil quality standard tests conducted on October 1 and 2 were both below the thresholds for concern (1.5 mg/L for water quality [11] and 400 mg/kg for soil quality [12]); subsequent tests also revealed the levels to be below the threshold values [13].
Figure 1
Map of the Gumi industrial complex and the surrounding residential area. The hydrogen fluoride spill area is designated by the red circle.
2052-4374-25-17-1.jpg
This study described and analyzed the demographic and clinical characteristics of patients who were treated at a general hospital for symptoms related to hydrogen fluoride exposure after the accident. In addition, we present the treatment experience of the outpatient clinic of the Department of Occupational and Environmental Medicine.
A total of 6,982 people were treated at a private medical institution for physical symptoms caused by the hydrogen fluoride spill from September 27 to October 21, 2012, and an additional 5,261 people visited the temporary on-site clinic provided by the Gumi Municipal Government; thus, a total of 12,243 people were treated for fluoride-related symptoms [10]. Among the 3 general hospitals near the accident site, this study analyzed patients treated for hydrogen fluoride exposure at a university hospital located approximately 9 km from the accident site. A total of 1,952 outpatients visited the university hospital over 17 days from the start of the accident (from September 27 to October 13, 2012) because of symptoms related to hydrogen fluoride exposure, including 3 people who died. There were 10 hospitalized patients during the same period, and an additional 2 were hospitalized after October 14, resulting in a total of 12 hospitalized patients. Medical records and questionnaires completed at the time of outpatient treatment of these patients were reviewed by 7 clinicians at the Department of Occupational and Environmental Medicine using the same survey method. A total of 1,952 outpatients were surveyed; 1,890(96.8%) were included in the final analysis after excluding the 62 patients for whom medical records were unavailable.
A questionnaire survey was conducted on the exposure characteristics and symptoms. But, the survey was not conducted at the emergency clinic, because the questionnaire could not be prepared. Outpatients who attended 6 days after the accident occurred were surveyed through a self-completed questionnaire. When completing the survey, prior consent was obtained using a consent form for the collection and use of personal information. The surveyed content included basic demographic information (e.g., occupation and residence), exposure characteristics after the spill (e.g., distance from the accident site and location other than indoors), main symptoms, accompanying symptoms, medical history, physical examination findings, prescriptions, and second visits.
During outpatient visits at the Department of Occupational and Environmental Medicine, regular blood tests, liver function index tests, electrolyte tests including serum calcium, chest radiographs, pulmonary function tests, and urine fluoride concentration tests were performed with patient consent. No tests were performed on patients who were asymptomatic, showed mild symptoms, or did not provide consent. Many patients who initially visited the hospital through the emergency room received treatment simultaneously and required immediate calcium gluconate inhalation therapy and eye wash treatment. Therefore, information regarding exposure, symptoms, and clinical test results could not be identified through the medical records of the majority of the patients who initially visited the emergency room.
Urine fluoride was measured as a biological index of exposure to quantify individual exposure. Immediately after the spill, there were no institutions in Korea that could immediately perform fluoride analysis. On October 5 (the eighth day after the spill), a urine fluoride analysis device was ordered. Sixty-six patients suspected of having been exposed to relatively high concentrations of hydrogen fluoride among the 217 patients who visited on that day were selected; these patients included 46 workers who normally worked at an office within 100 m of the accident site even after the spill and 20 patients who were arbitrarily selected by clinicians because of their severe symptoms. Urine samples were stored in a freezer at −20°C and analyzed using a fluoride-ion specific electrode analyzer (Orion Star A214, Thermo Fisher Scientific Inc., Japan) when analysis was possible after 2 weeks.
With respect to the occupations, the patients were classified as local residents, workers, firefighters, police, public officials, and others. Local residents were further classified into adjacent residents and other residents. Adjacent residents included those from the 2 villages close to and downwind of the accident site that suffered direct damage to crops and facilities. The rest were classified as other residents. Depending on the time of the hospital visit, those who visited within 3 and after 4 days of the accident were classified as early and late patients, respectively. In addition, the distance to the accident site was classified as within 100 m, from 100 m to 1 km, and over 1 km.
Data were analyzed using SPSS version 14 (SPSS, Inc., Chicago, IL, USA). The χ2 test and t-test were used for simple analyses, while χ2 trend analysis was used to analyze differences in symptoms and complaints with respect to the distance from the accident site. Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) adjusted for age and sex were used to compare clinical parameters.
A total of 12 patients were hospitalized owing to hydrogen fluoride exposure. Among them were 5 residents in the nearby area, 4 workers, 2 other residents, and 1 public officer. Eleven patients showed improvement after appropriate treatment and were discharged within 1 week, but 1 patient who was admitted on October 16 was hospitalized for 10 days. The chief complaints of the hospitalized patients were respiratory symptoms such as hemoptysis and dyspnea; gastrointestinal symptoms including nausea and indigestion; neurologic symptoms such as headache and numbness; sore throat; and lip pain. Three patients hospitalized due to hemoptysis presented with redness and edema in the bronchial mucosa and rebleeding during washing on bronchoscopy. However, they were discharged after several days of conservative treatment. The 2 patients who complained of gastrointestinal symptoms presented with ulcers and chronic atrophic gastritis, respectively, during endoscopic examination but were discharged when they showed improvement after medication. The patient who was hospitalized at the otorhinolaryngology department because of findings of acute throat injection was discharged after medication. No specific abnormalities were found on physical examinations or by clinical tests in the patients hospitalized in the respiratory and neurology departments for symptoms such as shortness of breath, headache, and numbness in the hands and feet; these patients were discharged after receiving conservative treatment for their symptoms (Table 1).
Table 1
Details of the 12 hospitalized patients
Age Gender Department Date of admission Date of discharge Chief complaints Diagnosis Exposure characteristics Clinical findings
30
M
IP
9/28
9/29
Dyspnea
Gas inhalation
Worker
No abnormal findings
51
F
IP
10/3
10/10
Hemoptysis
Bronchitis
Adjacent resident
Bronchoscopy ; hyperemic, both bronchi edematous
52
M
IP
10/3
10/8
Blood-tinged sputum
Bronchitis
Governmental officials
Bronchoscopy ; both bronchi hyperemic
44
F
IP
10/9
10/12
Dyspnea
Gas inhalation
Worker
No abnormal findings
52
F
IP
10/16
10/25
Dyspnea
Toxic effect of HF*
Adjacent resident
Anxiety
38
M
IP
10/24
10/26
Hemoptysis
Bronchitis
Worker
Bronchoscopy ; both bronchi hyperemic
44
F
IG
10/6
10/10
Nausea
Gastric ulcer
Adjacent resident
GIF ++ ; gastric ulcer
68
F
IG
10/9
10/12
Nausea
Gas inhalation
Adjacent resident
GIF; chronic atropic gastritis
25
F
ENT§
10/6
10/11
Sore throat
Acute pharyngotonsillitis
Worker
Pharyngeal injection
57
F
NR
10/4
10/8
Numbness
Numbness
Other resident (Intake of contaminated crops)
No abnormal findings
79
F
NR
10/9
10/12
Headache
Chronic tension headache
Adjacent resident
No abnormal findings
71 F PS ** 10/8 10/8 Lip pain Chemical burn on lower lip Other Resident (intake of contaminated crops) Swelling, erythema on lower lip
*Hydrogen fluoride, Internal medicine, pulmonology, Internal medicine, gastroenterology, §ENT; Otorhinolaryngology, Neurology, ** Plastric surgery, ++ Gastro-intestinal fiberscopy.
Regarding the distribution of time of hospital visits, 10 patients visited on the day of the accident (September 27) through the emergency room, followed by 157 and 9 patients on the first and second days after the accident, respectively. No patients visited the hospital on the third day after the accident (September 30), which was the Chuseok Holiday. From the fifth day after the accident, the number of visiting patients increased to 33, reaching 217 on the eighth day, decreasing to 70 on the tenth day, and then decreasing again after reaching a peak of 235 patients on the twelfth day (Figure 2).
Figure 2
Distribution of numbers of non-hospitalized patients by day.
2052-4374-25-17-2.jpg
Regarding the age distribution of the outpatients, the largest proportion of patients were in their 30 s (30.4%) followed by patients in their 40 s (21.2%), 20 s (17.9%), and those aged <9 years (5.8%). Men accounted for 52.8% of all patients. The departments that provided the initial treatment were occupational and environmental medicine (80.8%), pediatrics (7.2%), internal medicine (6.9%), emergency medicine (2.9%), ophthalmology (1.1%), and otorhinolaryngology (0.6%). Among the patients exposed to hydrogen fluoride, the largest proportion were residents (42.7%), with 11.2% and 31.5% of patients representing nearby and other residents, respectively; workers, police and public officials, and firefighters accounted for 39.9%, 3.6%, and 2.1% of the patients, respectively. At the time of the accident, 80.4% and 19.1% of the patients exposed to hydrogen fluoride were indoors and outdoors, respectively. A total of 176 (9.3%) patients visited the hospital within 3 days of the accident, while 1,714 (90.7%) visited 4 days after the accident, and these patients were classified as early and late patients, respectively. Regarding the distance from the accident site, 14.6%, 46.5%, and 38.9% of patients were within 100 m, 100 m to 1 km, and over 1 km, respectively, from the accident site (Table 2).
Table 2
General characteristics of non-hospitalized patients
Characteristic Number %
Age(years)
 
 
   0–9
109
5.8
   10–19
80
4.2
   20–29
338
17.9
   30–39
575
30.4
   40–49
400
21.2
   50–59
253
13.4
   ≥60
135
7.1
Gender
 
 
   Male
997
52.8
   Female
893
47.2
First visit to the outpatient department
 
 
   Occupational and environmental medicine
1528
80.8
   Pediatrics
136
7.2
   Internal medicine, Pulmonology
130
6.9
   Emergency medicine
55
2.9
   Ophthalmologic medicine
22
1.1
   Otorhinolaryngology
11
0.6
   Others
9
0.6
Exposure characteristics
 
 
   Adjacent residents
205
11.2
   Other residents
575
31.5
   Workers
728
39.9
   Firefighters
38
2.1
   Police and public officials
66
3.6
   Others
211
11.6
Location at the time of the accident
 
 
   Indoor
922
80.4
   Outdoor
219
19.1
   Others
6
0.5
Time of first hospital visit
 
 
   Within 3 days
176
9.3
   After 4 days
1714
90.7
Distance from the place of the accident spot
 
 
   Under 100 m
227
14.6
   100 m-1 km
721
46.5
   Over 1 km 603 38.9
The chief complaints reported by the patients were sore throat (24.1%), headache (19.1%), cough (13.2%), and eye irritation (9.2%); 6.2% of the patients were asymptomatic. The prevalence of shortness of breath was higher among early patients (27.0%) than among late patients (3.5%); nausea was also more prevalent in the early patients (6.3%) than the late patients (2.6%). In contrast, cough was more prevalent in the late patients (19.4%) than the early patients (5.0%). Moreover, there were more asymptomatic patients among the late patients (6.4%) than the early patients (3.8%) (p < 0.05) (Table 3).
Table 3
Chief complaints of early and late patients
Chief complaint Early patients *
Late patients
Total
p-value
N % N % N %
Sore throat
37
23.3
394
24.2
431
24.1
0.797
Headache
25
15.7
316
19.4
341
19.1
0.260
Cough
8
5.0
228
14.0
236
13.2
0.001
Eye irritation
17
10.7
147
9.0
164
9.2
0.487
No symptom
6
3.8
105
6.4
111
6.2
0.183
Shortness of breath
43
27.0
57
3.5
100
5.6
0.000
Chest pain
3
1.9
63
3.9
66
3.7
0.206
Dizziness
2
1.3
54
3.3
56
3.1
0.155
Nausea
10
6.3
43
2.6
53
3.0
0.010
Rhinorrhea
0
0.0
53
3.3
53
3.0
0.021
Skin burning
2
1.3
36
2.2
38
2.1
0.427
Itching
0
0.0
32
2.0
32
1.8
0.075
Sputum
1
0.6
26
1.6
27
1.5
0.340
Nasal pain
1
0.6
14
0.9
15
0.8
0.761
Skin rash
0
0.0
7
0.4
7
0.4
0.408
Vomiting
0
0.0
2
0.1
2
0.1
0.658
Others
4
2.5
52
3.2
56
3.1
0.640
Total 159 100.0 1629 100.0 1788 100.0  
* Early patients: hospital visit within 3 days.
† Late patients: hospital visit 4 days or after.
‡ Chi-squared test.
Regarding individual symptom complaints other than chief complaints, the most common complaints were cough (43.3%), sore throat (42.6%), and headache (41.9%). Shortness of breath was observed in 30.7% of the early patients but in only 14.7% of the late patients. Cough (15.3% and 46.1% in the early and late patients, respectively), headache (26.7% and 43.5%), eye irritation (19.9% and 31.3%), dizziness (5.1% and 15.2%), and skin rash (0.6% and 3.8%) were more prevalent in the late patients (Table 4).
Table 4
Symptom complaints of early and late patients
  Early patients *
Late patients
Total
p-value
N % N % N %  
Cough
27
15.3
791
46.1
818
43.3
0.000
Sore throat
64
36.4
741
43.2
805
42.6
0.079
Headache
47
26.7
745
43.5
792
41.9
0.000
Eye irritation
35
19.9
536
31.3
571
30.2
0.002
Nausea
25
14.2
327
19.1
352
18.6
0.114
Shortness of breath
54
30.7
252
14.7
306
16.2
0.000
Dizziness
9
5.1
260
15.2
269
14.2
0.000
Chest pain
5
2.8
102
6.0
107
5.7
0.089
Skin burning
5
2.8
77
4.5
82
4.3
0.306
Skin rash
1
0.6
65
3.8
66
3.5
0.027
Vomiting
2
1.1
45
2.6
47
2.5
0.227
Total 176 100.0 1714 100.0 1890 100.0  
* Early patients: hospital visit within 3 days.
† Late patients: hospital visit 4 days or after.
‡ Chi-squared test.
The patients’ characteristics were compared with respect to their distance from the accident site (i.e., within 100 m, 100 m to 1 km, and over 1 km). There were more men near the accident site: 18.3% of men were within 100 m compared to 10.6% of women. Regarding age, 63.3% of patients aged <19 years were located over 1 km away, while 11.8% and 21.2% of those aged 20–39 and 40–59 years were located within 100 m, respectively. Regarding those aged 60 years and over, 72.8% were located from 100 m to 1 km from the accident site. Regarding exposure characteristics, nearby residents accounted for a substantial number of patients, as 79.7% were located from 100 m to 1 km from the accident site, while 73.7% of the other residents were located over 1 km away. Regarding workers, 14.8% and 58.5% were within 100 m and from 100 m to 1 km, respectively. Among the early and late patients, 52.9% and 12.8% were within 100 m, respectively.
Physical examination findings were analyzed with respect to the distance from the accident site. Abnormal pulmonary sound was more common in patients closer to the site: 7.4%, 2.5%, and 1.0% were within 100 m, from 100 m to 1 km, and over 1 km away, respectively, from the site. Skin abnormalities were also common in the patients closer to the site: 9.7%, 6.7%, and 3.5% were within 100 m, from 100 m to 1 km, and over 1 km away, respectively, from the site. Among the 48 patients administered the pulmonary function test, 4 exhibited abnormal findings; however, there was no significant association with exposure distance (Table 5).
Table 5
Patient characteristics with respect to distance from the accident site
  Under 100 m
100m-1 km
Over 1 km
p-value*
N % N % N %
Sex
 
 
 
 
 
 
0.000
 Male
149
65.6
418
58.0
249
41.3
 
 Female
78
34.4
303
42.0
354
58.7
 
Age
 
 
 
 
 
 
0.000
 Under 19
7
3.1
22
3.0
50
8.3
 
 20~39
96
42.3
351
43.7
370
61.3
 
 40~59
117
51.5
273
37.9
162
26.9
 
 Over 60
7
3.1
75
10.4
21
3.5
 
Exposure characteristics
 
 
 
 
 
0.000
 Adjacent residents
12
5.4
126
17.6
20
3.3
 
 Other residents
12
5.4
103
14.4
323
53.7
 
 Workers
103
46.6
408
56.9
187
31.1
 
 Firefighters
19
8.6
1
0.1
3
0.5
 
 Public officials
9
4.1
8
1.1
5
0.8
 
 Others
66
29.9
71
9.9
64
10.6
 
Time of hospital visit
 
 
 
 
 
0.000
 Within 3 days
37
16.3
25
3.5
8
1.3
 
 4 days or after
190
83.7
696
96.5
595
98.7
 
Abnormal physical findings
 
 
 
 
 
 
 Throat
72/136
52.9
273/466
58.6
204/400
51.0
0.240
 Nose
10/80
12.5
25/248
10.1
16/223
7.2
0.126
 Eye
12/82
14.6
35/250
14.0
25/242
10.3
0.202
 Lung
7/95
7.4
8/326
2.5
3/303
1.0
0.001
 Heart
0/92
0.0
0/294
0.0
0/292
0.0
-
 Skin
7/72
9.7
15/225
6.7
8/229
3.5
0.002
Abnormal PFT
 
 
 
 
 
 
 
 FVC%
2/14
14.3
1/27
3.7
1/7
14.3
0.739
 FEV1/FVC% 0/14 0.0 2/27 7.4 0/7 0.0 0.747
* Chi-squared test for trend.
Decreased FVC < 80%.
Decreased FVC/FEV1 ratio <70%.
Upon analyzing the chief complaints with respect to distance, shortness of breath was found in 8.0%, 4.2%, and 3.4% of patients within 100 m, from 100 m to 1 km, and over 1 km away, respectively, from the site. In contrast, no symptoms and rhinorrhea were more common with increasing distance from the accident site. No symptoms were observed in 1.8%, 3.6%, and 6.1% of patients within 100 m, from 100 m to 1 km, and over 1 km away, respectively, from the site. Meanwhile, rhinorrhea was observed in 0.9%, 1.9%, and 4.7% of patients within 100 m, from 100 m to 1 km, and over 1 km away, respectively, from the site (Table 6).
Table 6
Chief complaints with respect to distance from the accident site
  Under 100 m
100 m-1 km
Over 1 km
p-value *
N % N % N %
Sore throat
51
22.7
195
28.2
131
23.5
0.660
Headache
46
20.4
142
20.5
106
19.0
0.549
Cough
27
12.0
87
12.6
82
14.7
0.234
Eye irritation
21
9.3
58
8.4
47
8.4
0.742
Shortness of breath
18
8.0
29
4.2
19
3.4
0.012
Chest pain
11
4.9
33
4.8
18
3.2
0.190
Dizziness
9
4.0
27
3.9
17
3.0
0.423
Nausea
3
1.3
26
3.8
14
2.5
0.784
Rhinorrhea
2
0.9
13
1.9
26
4.7
0.001
Skin burning
5
2.2
13
1.9
16
2.9
0.405
Itching
5
2.2
13
1.9
9
1.6
0.557
Sputum
8
3.6
7
1.0
10
1.8
0.289
Nasal pain
2
0.9
3
0.4
9
1.6
0.137
Skin rash
1
0.4
4
0.6
0
0.0
0.169
Vomiting
0
0.0
1
0.1
0
0.0
0.744
Others
12
5.3
16
2.3
20
3.6
0.548
No symptom
4
1.8
25
3.6
34
6.1
0.003
Total 225 100.0 692 100.0 558 100.0  
* Chi-squared test for trend.
Regarding the results of the blood tests and clinical chemistry tests, RBC, hematocrit, phosphorus, potassium, r-GTP, ALP, glucose, blood urea nitrogen, creatinine, and uric acid differed significantly according to the distance from the accident site. However, after adjusting for age and sex, the differences were only significant for hematocrit, potassium, and glucose. Blood hematocrit values increased with decreasing distance, with the values being 44.1 ± 4.44%, 43.5 ± 4.25%, and 41.9 ± 4.15% in patients within 100 m, from 100 m to 1 km, and over 1 km away, respectively. Potassium levels also increased with decreasing distance, with the levels being 4.13 ± 0.34, 4.07 ± 2.03, and 4.04 ± 0.28 mmol/L in patients within 100 m, from 100 m to 1 km, and over 1 km away, respectively. Glucose levels also increased with decreasing distance, with the levels being 113.0 ± 48.5, 105.5 ± 32.9, and 100.1 ± 20.9 mg/dL in patients within 100 m, from 100 m to 1 km, and over 1 km away, respectively (p < 0.05) (Table 7).
Table 7
Laboratory results with respect to distance from the accident site
 
Under 100 m
100 m-1 km
Over 1 km
Crude p-value Adjusted p-value*
  N Mean ± SD N Mean ± SD N Mean ± SD
Complete blood cell count
 
 
 
 
 
 
 
 
 WBC (×103/mm3)
166
6.97 ± 1.60
488
7.11 ± 1.97
471
6.99 ± 1.88
0.548
0.500
 RBC (×106/mm3)
166
4.88 ± 0.46
488
4.79 ± 0.48
471
4.70 ± 0.46
0.000
0.175
 Hemoglobin (g/dL)
166
14.8 ± 1.73
488
14.7 ± 1.67
471
14.0 ± 1.65
0.000
0.172
 Hematocrit (%)
166
44.1 ± 4.44
488
43.5 ± 4.25
471
41.9 ± 4.15
0.000
0.032
 Platelet (×103/mm3)
166
252.8 ± 55.9
488
246.8 ± 51.0
471
254.6 ± 50.7
0.057
0.101
Serum electrolyte
 
 
 
 
 
 
 
 
 
 
 
 Calcium (mg/dL)
172
9.39 ± 0.37
489
9.35 ± 0.36
471
9.32 ± 0.37
0.106
0.226
 Phosphorus (mg/dL)
172
3.57 ± 0.58
489
3.59 ± 0.57
471
3.74 ± 0.63
0.000
0.438
 Sodium (mmol/L)
165
141.9 ± 1.93
485
142.0 ± 2.06
471
141.7 ± 1.79
0.055
0.611
 Potassium (mmol/L)
165
4.13 ± 0.34
485
4.07 ± 0.32
471
4.04 ± 0.28
0.006
0.044
 Chloride (mmol/L)
164
102.9 ± 2.04
485
103.1 ± 2.03
471
103.1 ± 1.84
0.438
0.778
Serum chemistry
 
 
 
 
 
 
 
 
 
 
 
 AST (IU/L)
162
24.0 ± 10.8
476
25.3 ± 12.4
470
23.7 ± 13.5
0.161
0.310
 ALT (IU/L)
162
25.1 ± 16.6
476
26.9 ± 23.7
470
23.5 ± 25.1
0.087
0.466
 r-GTP§ (IU/L)
155
36.8 ± 31.6
473
39.3 ± 52.3
466
27.5 ± 28.9
0.000
0.240
 ALP (IU/L)
158
180.6 ± 62.6
475
177.6 ± 51.2
467
195.8 ± 130.3
0.010
0.136
 Glucose (mg/dL)
156
113.7 ± 48.5
461
105.5 ± 32.9
446
100.1 ± 20.9
0.000
0.038
 Total cholesterol (mg/dL)
159
197.6 ± 36.0
475
194.7 ± 36.0
467
190.7 ± 35.5
0.065
0.816
 Blood urea nitrogen (mg/dL)
161
13.9 ± 3.97
473
13.1 ± 3.89
468
12.7 ± 3.59
0.001
0.109
 Creatinine (mg/dL)
162
0.88 ± 0.14
473
0.89 ± 0.18
469
0.81 ± 0.19
0.000
0.070
 Uric acid (mg/dL) 152 5.62 ± 1.49 460 5.51 ± 1.47 444 5.12 ± 1.45 0.000 0.540
*Adjusted for age and sex, using ANCOVA test.
Aspartate transaminase, Alanine transaminase, §Gamma glutamyl transpeptidase, Alkaline phosphatase.
Calcium concentration was measured in 1,284 outpatients. The mean of the measured values was 9.37 mg/dL (range: 8.4–11.0 mg/dL). No patients had calcium levels below the threshold of 8.4 mg/dL. The mean urine fluoride level of the 66 samples collected on the eighth day after the accident was 0.39 ± 0.24 mg/L (range: 0.03–1.6 mg/L). All of the measurements were below 3 mg/g Cr, which is the pre-work exposure threshold provided by American Conference of Governmental Industrial Hygienists (ACGIH).
Hydrogen fluoride is a potent irritant that exists in a colorless gaseous or transparent liquid state. Pure hydrogen fluoride exists in a gaseous form at room temperatures over 19.5°C [14,15]. It is not explosive but generates heat when mixed with water; can react with metal, water, and steam; and can corrode silicon, glass, and concrete [9,16]. The Gumi spill involved 100% hydrogen fluoride. The fumes generated by the hydrogen fluoride combining with the moisture in the atmosphere were spread by the wind to adjacent areas, harming people, animals, and plants in the local community, as well as corroding buildings and cars due to their corrosive nature against metals and glass. Hydrogen fluoride which combines with the moisture in the mucous membranes of the human body can cause irritation first in the skin, eyes, and upper respiratory system including the nose and throat. Hydrogen fluoride gas is strongly hydrophilic and reactive in slightly acidic environments such as the body’s physiological acidity (pKa: 3.45); therefore, gas inhaled through the oral or nasal cavities is mostly absorbed into the upper respiratory tract. Inhaling large amounts of hydrogen fluoride gas can cause interstitial pneumonia and pulmonary edema, because the gas is absorbed by the lower respiratory tract as well [17,18]. In addition, hydrogen fluoride accumulating in the capillary tracheae is discharged into the upper tract because of ciliary action and enters the gastrointestinal system where it is ultimately absorbed by the gastrointestinal tract. This can cause gastrointestinal symptoms such as nausea, vomiting, and heartburn [14,16,17,19]. In this study, the chief complaints of outpatients in descending order were sore throat, headache, cough, and eye irritation, which are consistent with upper respiratory tract infection irritation symptoms due to hydrogen fluoride [20]. Many hospitalized patients who complained of gastrointestinal symptoms initially reported respiratory symptoms. Thus, the transition to gastrointestinal symptoms such as nausea and abdominal pain could be observed. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain are thought to be caused by bronchial ciliary action, which releases hydrogen fluoride into the gastrointestinal tract; this could have been caused or exacerbated by psychological stress. In addition, 19.1% of patients had headache as their chief complaint. Hydrogen fluoride can generate an irritating odor even at concentrations less than 1 ppm [9,21]. Furthermore, its potential to cause neurological symptoms may induce headache [19,22].
Fluoride ions are lipophilic and can easily penetrate the body, affecting the body by combining with calcium or magnesium [6,23]. Thus, hydrogen fluoride exposure can result in local symptoms such as burns as well as electrolyte abnormalities (e.g., hypocalcemia and hyperkalemia) by changing the concentrations of electrolytes such as calcium, magnesium, and potassium [20,24-28]. In this study, all outpatients had serum calcium within the normal range, and serum calcium did not vary with respect to the distance from the accident site. However, serum potassium was significantly higher in patients closer to the accident site. A study involving hydrofluoric acid burn cases reported that a delayed form of hyperkalemia can occur after exposure to hydrofluoric acid [24,29]. There are 2 possible mechanisms underlying the increase in blood potassium after fluoride exposure. The first is that fluoride ions deactivate Na+−K+ ATPase to increase extracellular potassium. The second involves the activation of the Na+−Ca2+ ion exchanger by fluoride ions, increasing intracellular calcium, which in turn activates calcium-dependent potassium channels to export potassium extracellularly. However, Vohra et al. [30] maintain that hyperkalemia is a phenomenon observed in some cases of hydrofluoric acid exposure and that the relationship between fluoride exposure and hyperkalemia remains unclear. Whether the high potassium concentrations in the patients who were close to the accident site were indeed due to hydrogen fluoride exposure will have to be identified through a detailed investigation in the future. In addition, hematocrit, and serum glucose increased significantly with decreasing distance to the accident site, even after adjusting for age and sex. Although it is possible that the increase in serum glucose in patients close to the accident site was due to physical and psychological stress, this also requires detailed study in the future. No lower respiratory tract lesions including pulmonary edema or interstitial pneumonitis were observed in any of the patients. Only 4 out of 48 subjects had abnormal pulmonary functioning test findings; however, a significant difference was not observed with respect to exposure distance. These results demonstrate that the effects of this accident were mostly limited to the upper respiratory tract. Furthermore, it can be assumed that the extent of hydrogen fluoride exposure was not to the point of being absorbed into the blood via the alveoli. However, 3 hospitalized patients had hemoptysis symptoms with findings of bronchitis caused by hydrogen fluoride. In addition, the majority of early patients visiting the emergency room complained of respiratory symptoms and were treated with calcium gluconate inhalation therapy. Thus, the patients exposed to relatively high concentrations of hydrogen fluoride in the initial phase of the accident suffered acute health effects severe enough to cause respiratory damage. Meanwhile, the patients who were victims of the secondary health damage caused by the hydrogen fluoride that subsequently spread through the community suffered acute health effects limited to the upper respiratory tract.
Hydrogen fluoride absorbed into the body has a half-life of 2–9 h in the blood [31], and approximately 60% is excreted into the urine within 24 h. Meanwhile, 99% of fluoride compounds not excreted are deposited in the bones as fluorapatite [32], which may lead to bone disease and fluorosis with long-term exposure [23,32-35]. In this study, urine fluoride measurements as a biological index of hydrogen fluoride accumulation in the body were attempted, but meaningful results could not be obtained, because the institution and equipment required for the test were unavailable during the early phase of the exposure. The mean and maximum urine fluoride levels of 66 samples analyzed after 2 weeks were 0.39 and 1.6 mg/L, respectively, both of which are below the threshold value. The threshold values of urine fluoride before and after work are reported to be 3 and 10 mg/g Cr by the ACGIH and 4 and 7 mg/g Cr by the German Research Federation (DFG). Urine fluoride can be affected by various conditions such as water intake and sweating; therefore, creatinine-adjusted values must be calculated. The creatinine-adjusted concentration is calculated by dividing the measured concentration by the urine creatinine concentration. However, this study has a limitation in that adjusted values were not calculated because urine creatinine was not measured. Since the urine creatinine concentration in a typical adult is 1.0–1.6 g/L, it can be assumed that the urine fluoride levels of the patients in this study were still below the threshold regardless of the fact that adjusted creatinine could not be calculated. Although our estimation of the initial exposure circumstances is limited by late urine sampling in outpatients, it can be assumed that the patients were not significantly exposed to hydrogen fluoride for at least 8 days after the accident.
There are few cases in the literature reporting the health effects of hydrogen fluoride spills in local communities. The most well-documented case in the literature is the hydrogen fluoride spill that occurred in Texas in 1987 [1,36]; although accidents occurred in Oklahoma in 1988 and Mexico in 1991, there were no studies systematically documenting the health effects due to these accidents [37-39]. In the accident that occurred in Texas in 1987, 24 tons of hydrogen fluoride were spilled by an oil company and 3,000 residents within an 800-m radius evacuated the area within 20 min of the accident. The acute health effects in patients visiting 2 hospitals after the accident were analyzed; the major symptoms reported by the patients included eye irritation (56%), sore throat (21%), headache (20.6%), and shortness of breath (19.4%), which are similar to the symptoms reported by the patients in the present study [1]. In addition, in a study that followed 10,811 residents 2 years after exposure, the extent of hydrogen fluoride exposure as well as respiratory and eye symptoms exhibited a significant dose–response relationship; furthermore, 30–40% of the people in the high-exposure group reported respiratory and eye symptoms even after 2 years [36]. These results may have been affected by a potential recall bias. However, the fact that a substantial proportion of subjects in a large-scale follow-up study showed symptoms even after 2 years warrants detailed follow-up regarding the long-term health effects caused by the Gumi hydrogen fluoride spill as well.
It is essential to evaluate the extent of exposure of every individual in order to precisely identify the health effects following the spill. However, it was impossible to measure direct exposure indices such as the atmospheric hydrogen fluoride concentration with respect to distance or the individual biological exposure index in the present study. Therefore, variables reflecting exposure levels, the timing of hospital visits after the accident, and the distance from the accident site at the time of accident were analyzed as indices that indirectly reflect the exposure level. Regarding the analysis of chief complaints with respect to the distance from the accident site, patients who reported shortness of breath as a chief complaint were closer, while complaints of rhinorrhea and no symptoms were more frequent with increasing distance. The results are concordant with the assumption that more cases of lower respiratory tract symptoms (e.g., shortness of breath) would be observed in patients closer to the accident site because of the exposure to higher concentrations of hydrogen fluoride. Meanwhile, the fact that patients who reported rhinorrhea as a chief complaint were far away from the site suggests that hydrogen fluoride exposure is unlikely to cause rhinorrhea. Another index measured in the present study was the timing of hospital visits. Early patients reported shortness of breath and nausea as chief complaints, while late patients reported cough and rhinorrhea. It can be assumed that the early patients, who visited within 3 days, were exposed to high concentrations of hydrogen fluoride, while the late patients, who visited after 4 days, included many patients with upper respiratory tract symptoms such as cough and rhinorrhea in addition to those who reported symptoms caused by low concentrations of hydrogen fluoride due to secondary community contamination.
One unusual aspect of this accident is that the hospital visits exhibited a bipolar distribution. The distribution of patients visiting the hospital showed 3 peaks on the first, eighth, and twelfth day from the accident; the decreases between the eighth and twelfth days are because the ninth and tenth days were weekend days. Thus, it can be assumed that the local residents postponed hospital visits until Monday. Most outpatients started visiting the hospital beginning on the sixth day after the accident, increasing until the twelfth day. Further, 9 out of 12 hospitalized patients were admitted 1 week after the accident. Diluted fluoride may take time to penetrate the tissues, and symptoms may be delayed for 2–3 days [27,40]. In addition, the possibility that the hydrogen fluoride lingered in the local community cannot be excluded. Therefore, it was possible that the patients’ symptoms could have developed after a certain delay from the accident or the mild initial symptoms could have worsened over time. However, this likelihood alone cannot explain the fact that the number of outpatients peaked 12 days after the accident and the total number kept increasing for over 16 days. The accident occurred while the season was changing when upper respiratory tract infections are common. Therefore, many residents may have believed upper respiratory tract infection symptoms such as cough, rhinorrhea , and sore throat were related to the hydrogen fluoride. As a consequence, some of the outpatients visiting because of hydrofluoric acid exposure may have, in fact, had unrelated simple upper respiratory tract infection symptoms. The inadequate responses of the government and relevant organizations to the hydrogen fluoride spill may have increased the distrust of residents, and the stimulating news reported daily may have had psychological effects. It will be necessary to consider the psychological and physical effects caused by hydrogen fluoride exposure as well as the relationships between hydrogen fluoride exposure and physical symptoms through detailed assessments of health effects in the future. Only with the assessment of psychological components, the whole effect of hydrogen fluoride exposure on health can be precisely determined [41].
In this study, the data analysis of the acute effects of hydrogen fluoride was limited because of a lack of information about the medical history and exposure level of the early patients. In particular, health effect evaluation and data collection were not performed for the firefighters or public officials on site, whose health risk was of greatest concern. For the early patients who visited the emergency room, medical history surveys were rarely performed and clinical tests could not be performed. Detailed medical history surveys and clinical tests were impossible because of the disaster triage situation. More information could have been gathered and this information could have aided patient care if the medical staff of the Departments of Occupational and Environmental Medicine and Emergency Medicine had cooperated immediately after the accident. Although some atmospheric measurements of the hydrogen fluoride concentration were taken after the spill, they could not be used as an index to clarify the exposure level, as they were neither systematic nor precise. Another limitation of the study is that a considerable amount of time had elapsed before biological samples for the biological exposure index analysis were stored and structured surveys were administered. This study included a total of 1,890 patients, accounting for 15.4% of the 12,243 people who received treatment for hydrofluoric acid reported by the Gumi Municipal Government until October 21, 2012. Excluding the 5,261 patients who visited the temporary on-site free clinic, the present cohort accounts for 27.0% of 6,982 patients. The facts that not all of the patients were surveyed and data from only one hospital were analyzed are also limiting factors of this study. This incident warrants the establishment of a system that would enable the medical staff of the Department of Occupational and Environmental Medicine to immediately intervene in situations involving environmental disease due to chemical substances. The outpatient clinic of the Department of Occupational and Environmental Medicine also needs to develop a system to identify the level of exposure of individual patients and be equipped to face large-scale environmental disasters that occur without warning.
The chronic health effects of fluoride and hydrogen fluoride, including skeletal and dental fluorosis, have only been reported among residents living in areas where drinking water contains high concentrations of fluoride or workers who have long-term exposure to fluoride during the aluminum smelting process [9,32,42,43]. This accident was a one-time acute spill. On the basis of the symptoms and clinical test results from outpatients, neither the fluoride exposure level nor the exposure period is believed to have been sufficient to cause skeletal or dental fluorosis. However, monitoring the health of exposed residents is necessary because of the unique aspects of the Gumi spill and the lack of data about the long-term health effects after acute hydrogen fluoride exposure. Considering that after the spill in Texas in 1987, several cases in the high-exposure group had symptoms persisting even after 2 years, the possibility of prolonged physical and psychological symptoms in local community members cannot be ruled out. In particular, the initial investigation was inadequate regarding mental health aspects such as depression and post-traumatic stress disorder. Therefore, continuous follow-up observations on long-term psychological and physical health are necessary.
The patients exposed to relatively high concentrations of hydrogen fluoride in the initial phase of the accident suffered acute health effects severe enough to cause respiratory damage. Meanwhile, the patients who were victims of the secondary health damage caused by community spread suffered by symptoms limited to the upper respiratory tract such as sore throat, headache, cough, and eye irritation. However, monitoring the health of exposed residents is necessary because of the unique aspects of the Gumi spill and the lack of data about the long-term health effects after acute hydrogen fluoride exposure.
The authors declare that they have no competing interests.
All authors had access to the data and played a role in writing this manuscript. JSK conceived and designed the study. SYY and SYC were involved in writing the manuscript. SIU and JAK performed the data collection. JSK and JYN performed the statistical analysis, the interpretation of data. KHW had critically revised the manuscript. All authors read and approved the final manuscript.
This work was supported by the Soonchunhyang University Gumi Hospital Environmental Health Center Research Fund.
  • Wing JS, Brender JD, Sanderson LM, Perrotta DM, Beauchamp RA: Acute health effects in a community after a release of hydrofluoric acid. Arch Environ Health 1991;25(3):155–160. 10.1080/00039896.1991.9937443. 2039270.Article
  • Madden EF, Fowler BA: In: , editor. Metal compounds and rare earths. Environmental and Occupational Medicine. 2007, 4. Philadelphia: Lippincott-Raven Publication; 1085–1087.
  • Lund K, Refsnes M, Ramis I, Dunster C, Boe J, Schwarze PE, Skovlund E, Kelly FJ, Kongerud J: Human exposure to hydrogen fluoride induces acute neutrophilic, eicosanoid, and antioxidant changes in nasal lavage fluid. Inhal Toxicol 2002;25:119–132. 10.1080/089583701753403944. 12122575.Article
  • Office of Environmental Health Hazard Assessment. Acute toxicity summary of fluorides including hydrogen fluoride. http://www.oehha.ca.gov.
  • Wong A, Greene S, Robinson J: Hydrofluoric acid poisoning: data from the Victorian Poisons Information Centre. Emerg Med Australas 2012;25:98–101. 10.1111/j.1742-6723.2011.01485.x. 22313566.Article
  • Kirkpatrick JJR, Enion DS, Burd DAR: Hydrofluoric acid burns: a review. Burns 1995;25:483–493. 10.1016/0305-4179(95)93254-H. 8540973.Article
  • Office of Environmental Health Hazard Assessment. Chronic toxicity summary of fluorides including hydrogen fluoride. http://www.oehha.ca.gov.
  • Centers for Disease Control and Prevention. The National Institute for Occupational Safety and Health: Occupational health guidelines for chemical hazards. http://www.cdc.gov.
  • United States Environmental Protection Agency. Hydrogen fluoride study(Final report). http://www.epa.gov.
  • Gumi City: Report of explosion accident in HUBE Global Inc.(translated by Na JY). http://www.gumi.go.kr.
  • Chae GT, Yun ST, Mayer B, Kim KH, Kim SY, Kwon JS, Kim KJ, Koh YK: Fluorine geochemistry in bedrock groundwater of South Korea. Sci Total Environ 2007;25:272–283. 10.1016/j.scitotenv.2007.06.038. 17655916.Article
  • Ministry of Environment. Standards of soil contamination concern and measures in Soil Environment Conservation Act(translated by Na JY). http://www.me.go.kr (Korean).
  • National Institute of Environmental Research. Report of misunderstanding and the truth about hydrogen fluoride(translated by Na JY). http://www.nier.go.kr (Korean).
  • Waldbott GL, Lee JR: Toxicity from repeated low-grade exposure to hydrogen fluoride-case report. ClinToxicol 1978;25:391–402.Article
  • Korea Occupational Safety and Health Agency. Material Safety Data Sheet(MSDS). http://www.kosha.or.kr.
  • United States Environmental Protection Agency. Summery review of health effects associated with hydrogen fluoride and related compounds: health issue assessment. http://www.epa.gov.
  • Lund K, Ekstrand J, Boe J, Søstrand P, Kongerud J: Exposure to hydrogen fluoride: an experimental study in humans of concentrations of fluoride in plasma, symptoms, and lung function. Occup Environ Med 1997;25:32–37. 10.1136/oem.54.1.32. 9072031.ArticlePubMedPMC
  • Bennion JR, Franzblau A: Chemical pneumonitis following household exposure to hydrofluoric acid. Am J Ind Med 1997;25:474–478. 10.1002/(SICI)1097-0274(199704)31:4<474::AID-AJIM15>3.0.CO;2-X. 9093664.Article
  • Agency for Toxic Substances and Disease Registry. Toxicological profile for fluorides, hydrogen fluoride and fluorine. http://www.atsdr.cdc.gov.
  • Seo IK, Kim SJ: A case of successful management of inhalation injury caused by hydrofluoric acid poisoning. Korean Soc Emerg Med 2011;25(1):116. Korean.
  • Centers for Disease Control and Agency for Toxic Substances and Disease Registry. Hydrogen fluoride(HF). http://www.atsdr.cdc.gov.
  • Nabavi S, Sureda A, Nabavi S, Mohammad A, Moghaddam A, Moghaddam H, Moghaddam C: Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress. J Fluorine Chem 2012;25:79–82.Article
  • Hatzifotis M, Williams A, Muller M, Pegga S: Hydrofluoric acid burns. Burns 2004;25:156–159. 10.1016/j.burns.2003.09.031. 15019125.Article
  • Wu ML, Deng JF, Fan JS: Survival after hypocalcemia, hypomagnesemia, hypokalemia and cardiac arrest following mild hydrofluoric acid burn. J Clin Toxicol 2010;25:953–955. 10.3109/15563650.2010.533676.Article
  • Chapa L, Surani S, Varon J: Management of hydrofluoric acid injury in the emergency department and critical care units. Crit Care Shock 2009;25:117–119.
  • Gallerani M, Bettoli V, Peron L, Manfredini R: Systemic and topical effects of intradermal hydrofluoric acid. Am J Emerg Med 1998;25:521–522. 10.1016/S0735-6757(98)90008-0. 9725972.Article
  • Dalamaga M, Karmaniolas K, Nikolaidou A, Papadavid E: Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury. J Burn Care Res 2008;25(3):541–543. 10.1097/BCR.0b013e3181711152. 18388571.Article
  • Blodgett DW, Suruda AJ, Crouch BI: Fatal unintentional occupational poisonings by hydrofluoric acid in the U.S. Am J Ind Med 2001;25:215–220. 10.1002/ajim.1090. 11494350.Article
  • Binh TL: In: , editor. Hydrogen fluoride and hydrofluoric acid. Poisoning & Drug Overdose. 2004, 4. Singapore: McGraw Hil; 221–224.
  • Vohra R, Velez LI, Rivera W, Benitez FL, Delaney KA: Recurrent life-threatening ventricular dysrhythmias associated with acute hydrofluoric acid ingestion: observations in one case and implications for mechanism of toxicity. J Clin Toxicol 2008;25:79–84. 10.1080/15563650701639097.Article
  • Sucman E, Bednarr J: Determination of fluoride in plant material using microwave induced oxygen combustion. Czech J Food Sci 2012;25:438–441.
  • Kim JY, Lim HS, Cheong HK, Lee HK, Kang HS: A study on the change of the bone density among workers exposed to hydrofluoric acid. Korean J Occup Environ Med 1995;25:120–127. Korean.ArticlePDF
  • Ohata U, Hara H, Suzuki H: 7 Cases of hydrofluoric acid burn in which calcium gluconate was effective for relief of severe pain. Contact Dermatitis 2005;25:133–137. 10.1111/j.0105-1873.2005.00521.x. 15811026.Article
  • Song YE, Tan H, Liu KJ, Zhang YZ, Liu Y, Lu CR, Yu DL, Tu J, Cui CY: Effect of fluoride exposure on bone metabolism indicators ALP, BALP, and BGP. Environ Health Prev Med 2011;25:158–163. 10.1007/s12199-010-0181-y. 21431799.ArticlePubMedPMCPDF
  • Bmmml J, Stoβ H, Zober A: Intoxication following the inhalation of hydrogen fluoride. Arch Toxicol 1984;25:50–54. 10.1007/BF00316353. 6517713.
  • Dayal HH, Brodwick M, Morris R, Baranowski T, Trieff N, Harrison JA, Lisse JR, Ansari GAS: A community based epidemiologic study of health sequelae of exposure to hydrofluoric acid. Ann Epidemiol 1992;25:213–230. 10.1016/1047-2797(92)90054-T. 1342272.ArticlePubMed
  • United States Environmental Protection Agency. Acute exposure guideline levels for selected airborne chemicals vol. 4. http://www.epa.gov.
  • United States Environmental Protection Agency. Hydrofluoric acid exposures: long-term effects. http://www.epa.gov.
  • Himes JE: Occupational medicine in Oklahoma: hydrofluoric acid dangers. J Okla State Med Assoc 1989;25:567–569. 2614557.
  • Dünser MW, Ohlbauer M, Rieder J, Zimmermann I, Ruatti H, Schwabegger AH, Bodrogi F, Huemer GM, Friesenecker BE, Mayr AJ, Lirk P: Critical care management of major hydrofluoric acid burns: a case report, review of the literature, and recommendations for therapy. Burns 2004;25:391–398. 10.1016/j.burns.2004.01.005. 15145201.
  • Dayal H, Baranowski T, Li YH, Morris R: Hazardous chemicals: psychological dimensions of the health sequelae of a community exposure in Texas. J Epidemiol Community Health 1994;25:560–568. 10.1136/jech.48.6.560. 7830010.Article
  • Luo KL, Liu YL, Li HJ: Fluoride content and distribution pattern in groundwater of eastern Yunnan and western Guizhou. China Environ Geochem Health 2012;25:89–101. 10.1007/s10653-011-9393-3.
  • Whyte M, Essmyer K, Gannon F, Reinus W: Skeletal fluorosis and instant tea. Am J Med 2005;25:78–82. 10.1016/j.amjmed.2004.07.046. 15639213.Article

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Effect of Origin on Chemical Extractability of Fluorine in Soil and Its Consequence on Human Health Risk
      Changwon Chae, Soobean Park, Sang-Gyu Yoon, Jinsung An
      KSCE Journal of Civil Engineering.2024;[Epub]     CrossRef
    • Nitrogen-Doped Graphene Quantum Dots for Efficient Detection of Toxic Gas
      Modhurima Bhuiya, Saurav Kumar, Aman Kumar, Neha Agnihotri
      Journal of Electronic Materials.2024; 53(7): 3569.     CrossRef
    • The Effect of Prior Mental Health on Persistent Physical Symptoms after Exposure to a Chemical Disaster
      Young-Sun Min, Soo-Young Kim, Sun-Kyeong Choi, Yeon-Soon Ahn
      Healthcare.2023; 11(7): 1004.     CrossRef
    • Froth-Flotation Separation as an Alternative for the Treatment of Soil Enriched with Fluorine Derived from Mica
      Jeonghwan Cho, Moon Young Jung, Hwan Lee, Jinsung An
      International Journal of Environmental Research and Public Health.2022; 19(3): 1775.     CrossRef
    • An outbreak of neurologic symptoms among patients exposed to an unknown stench in a high school near an industrial complex: an epidemiological investigation
      Kiook Baek, Seongmin Jo, Chulyong Park, Joon Sakong
      Epidemiology and Health.2022; 44: e2022105.     CrossRef
    • Lessons Learned from Major Environmental Health Disasters in South Korea and the Role of Environmental Health Experts
      Jong-Ju Ahn
      Journal of Environmental Health Sciences.2022; 48(1): 9.     CrossRef
    • Comparative Analysis of Hydrogen Fluoride-Exposed Patients Based on Major Burn Criteria After the 2012 Gumi City Chemical Leak Disaster
      Heejun Shin, Se Kwang Oh, Han You Lee, Heajin Chung, Seong Yong Yoon, Sung Yong Choi
      Journal of Burn Care & Research.2022; 43(4): 834.     CrossRef
    • Lessons learned from reviewing a hospital’s disaster response to the hydrofluoric acid leak in Gumi city in 2012
      Heejun Shin, Se Kwang Oh, Han You Lee, Heajin Chung, Seong Yong Yoon, Sung Yong Choi, Jae Hyuk Kim
      BMC Emergency Medicine.2021;[Epub]     CrossRef
    • Chemical pneumonitis by prolonged hydrogen fluoride inhalation
      Young Jin Lee, In Beom Jeong
      Respiratory Medicine Case Reports.2021; 32: 101338.     CrossRef
    • Application of calcium nebulization for mass exposure to an accidental hydrofluoric acid spill
      Michael Sung Pil Choe, Mi Jin Lee, Kang Suk Seo, Sin Kam, Keon Yeop Kim, Dongwook Je, Seong Hun Kim, Woo Young Nho, Hong In Park, Sujeong Shin, Hyun Wook Ryoo
      Burns.2020; 46(6): 1337.     CrossRef
    • De novo synthesis and particle size control of iron metal organic framework for diclofenac drug delivery
      Pamela Berilyn So, Hsin-Tsung Chen, Chia-Her Lin
      Microporous and Mesoporous Materials.2020; 309: 110495.     CrossRef
    • Emergency Evacuation Plan for Hazardous Chemicals Leakage Accidents Using GIS-based Risk Analysis Techniques in South Korea
      Byungtae Yoo, Sang D. Choi
      International Journal of Environmental Research and Public Health.2019; 16(11): 1948.     CrossRef
    • SF4 as the Fluorination Reactant for Al2O3 and VO2 Thermal Atomic Layer Etching
      Jonas C. Gertsch, Austin M. Cano, Victor M. Bright, Steven M. George
      Chemistry of Materials.2019; 31(10): 3624.     CrossRef
    • Public health risk management case concerning the city of Isfahan according to a hypothetical release of HF from a chemical plant
      Mansour R. Azari, Asghar Sadighzadeh, Majid Bayatian
      Environmental Science and Pollution Research.2018; 25(25): 24704.     CrossRef
    • Psychological Risk Factors for Posttraumatic Stress Disorder in Workers After Toxic Chemical Spill in Gumi, South Korea
      Ji Young Song, Kyoung-Sook Jeong, Kyeong-sook Choi, Min-gi Kim, Yeon-Soon Ahn
      Workplace Health & Safety.2018; 66(8): 393.     CrossRef
    • Combined acute inhalation of hydrofluoric acid and nitric acid: a case report and literature review
      Lucas Steverlynck, Nele Baert, Walter Buylaert, Peter De Paepe
      Acta Clinica Belgica.2017; 72(4): 278.     CrossRef
    • Soil microbial community responses to acid exposure and neutralization treatment
      Doyun Shin, Yunho Lee, Jeonghyun Park, Hee Sun Moon, Sung Pil Hyun
      Journal of Environmental Management.2017; 204: 383.     CrossRef
    • Short-term health effects in the general population following a major train accident with acrylonitrile in Belgium
      K. Simons, T. De Smedt, C. Stove, P. De Paepe, M. Bader, B. Nemery, C. Vleminckx, K. De Cremer, I. Van Overmeire, S. Fierens, B. Mertens, T. Göen, T. Schettgen, H. Van Oyen, J. Van Loco, A. Van Nieuwenhuyse
      Environmental Research.2016; 148: 256.     CrossRef
    • How Do I Diagnose and Treat Workers With Injuries From Hydrofluoric Acid?

      Journal of Occupational & Environmental Medicine.2016; 58(7): e275.     CrossRef
    • Physical therapy performance in the rehabilitation of survivors of the Kiss nightclub tragedy: an experience report
      Isabella Martins de Albuquerque, Maria Elaine Trevisan, Adriane Schmidt Pasqualoto, Ana Lucia Cervi Prado, Marisa Bastos Pereira, Ana Fátima Viero Badaró
      Fisioterapia em Movimento.2015; 28(4): 649.     CrossRef
    • Development of Mobile Vortex Wet Scrubber and Evaluation of Gas Removal Efficiency
      Ji Hyun Kwak, Seung-Ryul Hwang, Yeon-Hee Lee, Jae-Young Kim, Ki Bong Song, Kyun Kim, Jae Eun Kang, Sang Jae Lee, Junho Jeon, Jin Hwan Lee
      Korean Journal of Environmental Agriculture.2015; 34(2): 134.     CrossRef
    • Performance Evaluation of Hazardous Substances using Measurement Vehicle of Field Mode through Emergency Response of Chemical Incidents
      Yeon-Hee Lee, Seung-Ryul Hwang, Jae-Young Kim, Kyun Kim, Ji Hyun Kwak, Min Sun Kim, Joong Don Park, Junho Jeon, Ki Joon Kim, Jin Hwan Lee
      Korean Journal of Environmental Agriculture.2015; 34(4): 294.     CrossRef
    • Fluorine distribution in soil in the vicinity of an accidental spillage of hydrofluoric acid in Korea
      Jinsung An, Hyun A Lee, Junseok Lee, Hye-On Yoon
      Chemosphere.2015; 119: 577.     CrossRef
    • Acute health effects of accidental chlorine gas exposure
      Joo-An Kim, Seong-Yong Yoon, Seong-Yong Cho, Jin-Hyun Yu, Hwa-Sung Kim, Gune-Il Lim, Jin-Seok Kim
      Annals of Occupational and Environmental Medicine.2014;[Epub]     CrossRef
    • Acute Symptoms in Firefighters who Participated in Collection Work after the Community Hydrogen Fluoride Spill Accident
      Seong-Yong Cho, Kuck-Hyun Woo, Jin-Seok Kim, Seong-Yong Yoon, Joo-Yong Na, Jin-Hyun Yu, Yong-Bae Kim
      Annals of Occupational and Environmental Medicine.2013; 25(1): 36.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Acute Symptoms after a Community Hydrogen Fluoride Spill
      Ann Occup Environ Med. 2013;25:17-17.   Published online September 19, 2013
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    Acute Symptoms after a Community Hydrogen Fluoride Spill
    Image Image
    Figure 1 Map of the Gumi industrial complex and the surrounding residential area. The hydrogen fluoride spill area is designated by the red circle.
    Figure 2 Distribution of numbers of non-hospitalized patients by day.
    Acute Symptoms after a Community Hydrogen Fluoride Spill
    AgeGenderDepartmentDate of admissionDate of dischargeChief complaintsDiagnosisExposure characteristicsClinical findings
    30
    M
    IP
    9/28
    9/29
    Dyspnea
    Gas inhalation
    Worker
    No abnormal findings
    51
    F
    IP
    10/3
    10/10
    Hemoptysis
    Bronchitis
    Adjacent resident
    Bronchoscopy ; hyperemic, both bronchi edematous
    52
    M
    IP
    10/3
    10/8
    Blood-tinged sputum
    Bronchitis
    Governmental officials
    Bronchoscopy ; both bronchi hyperemic
    44
    F
    IP
    10/9
    10/12
    Dyspnea
    Gas inhalation
    Worker
    No abnormal findings
    52
    F
    IP
    10/16
    10/25
    Dyspnea
    Toxic effect of HF*
    Adjacent resident
    Anxiety
    38
    M
    IP
    10/24
    10/26
    Hemoptysis
    Bronchitis
    Worker
    Bronchoscopy ; both bronchi hyperemic
    44
    F
    IG
    10/6
    10/10
    Nausea
    Gastric ulcer
    Adjacent resident
    GIF ++ ; gastric ulcer
    68
    F
    IG
    10/9
    10/12
    Nausea
    Gas inhalation
    Adjacent resident
    GIF; chronic atropic gastritis
    25
    F
    ENT§
    10/6
    10/11
    Sore throat
    Acute pharyngotonsillitis
    Worker
    Pharyngeal injection
    57
    F
    NR
    10/4
    10/8
    Numbness
    Numbness
    Other resident (Intake of contaminated crops)
    No abnormal findings
    79
    F
    NR
    10/9
    10/12
    Headache
    Chronic tension headache
    Adjacent resident
    No abnormal findings
    71FPS ** 10/810/8Lip painChemical burn on lower lipOther Resident (intake of contaminated crops)Swelling, erythema on lower lip
    CharacteristicNumber%
    Age(years)
     
     
       0–9
    109
    5.8
       10–19
    80
    4.2
       20–29
    338
    17.9
       30–39
    575
    30.4
       40–49
    400
    21.2
       50–59
    253
    13.4
       ≥60
    135
    7.1
    Gender
     
     
       Male
    997
    52.8
       Female
    893
    47.2
    First visit to the outpatient department
     
     
       Occupational and environmental medicine
    1528
    80.8
       Pediatrics
    136
    7.2
       Internal medicine, Pulmonology
    130
    6.9
       Emergency medicine
    55
    2.9
       Ophthalmologic medicine
    22
    1.1
       Otorhinolaryngology
    11
    0.6
       Others
    9
    0.6
    Exposure characteristics
     
     
       Adjacent residents
    205
    11.2
       Other residents
    575
    31.5
       Workers
    728
    39.9
       Firefighters
    38
    2.1
       Police and public officials
    66
    3.6
       Others
    211
    11.6
    Location at the time of the accident
     
     
       Indoor
    922
    80.4
       Outdoor
    219
    19.1
       Others
    6
    0.5
    Time of first hospital visit
     
     
       Within 3 days
    176
    9.3
       After 4 days
    1714
    90.7
    Distance from the place of the accident spot
     
     
       Under 100 m
    227
    14.6
       100 m-1 km
    721
    46.5
       Over 1 km60338.9
    Chief complaintEarly patients *
    Late patients
    Total
    p-value
    N%N%N%
    Sore throat
    37
    23.3
    394
    24.2
    431
    24.1
    0.797
    Headache
    25
    15.7
    316
    19.4
    341
    19.1
    0.260
    Cough
    8
    5.0
    228
    14.0
    236
    13.2
    0.001
    Eye irritation
    17
    10.7
    147
    9.0
    164
    9.2
    0.487
    No symptom
    6
    3.8
    105
    6.4
    111
    6.2
    0.183
    Shortness of breath
    43
    27.0
    57
    3.5
    100
    5.6
    0.000
    Chest pain
    3
    1.9
    63
    3.9
    66
    3.7
    0.206
    Dizziness
    2
    1.3
    54
    3.3
    56
    3.1
    0.155
    Nausea
    10
    6.3
    43
    2.6
    53
    3.0
    0.010
    Rhinorrhea
    0
    0.0
    53
    3.3
    53
    3.0
    0.021
    Skin burning
    2
    1.3
    36
    2.2
    38
    2.1
    0.427
    Itching
    0
    0.0
    32
    2.0
    32
    1.8
    0.075
    Sputum
    1
    0.6
    26
    1.6
    27
    1.5
    0.340
    Nasal pain
    1
    0.6
    14
    0.9
    15
    0.8
    0.761
    Skin rash
    0
    0.0
    7
    0.4
    7
    0.4
    0.408
    Vomiting
    0
    0.0
    2
    0.1
    2
    0.1
    0.658
    Others
    4
    2.5
    52
    3.2
    56
    3.1
    0.640
    Total159100.01629100.01788100.0 
     Early patients *
    Late patients
    Total
    p-value
    N%N%N% 
    Cough
    27
    15.3
    791
    46.1
    818
    43.3
    0.000
    Sore throat
    64
    36.4
    741
    43.2
    805
    42.6
    0.079
    Headache
    47
    26.7
    745
    43.5
    792
    41.9
    0.000
    Eye irritation
    35
    19.9
    536
    31.3
    571
    30.2
    0.002
    Nausea
    25
    14.2
    327
    19.1
    352
    18.6
    0.114
    Shortness of breath
    54
    30.7
    252
    14.7
    306
    16.2
    0.000
    Dizziness
    9
    5.1
    260
    15.2
    269
    14.2
    0.000
    Chest pain
    5
    2.8
    102
    6.0
    107
    5.7
    0.089
    Skin burning
    5
    2.8
    77
    4.5
    82
    4.3
    0.306
    Skin rash
    1
    0.6
    65
    3.8
    66
    3.5
    0.027
    Vomiting
    2
    1.1
    45
    2.6
    47
    2.5
    0.227
    Total176100.01714100.01890100.0 
     Under 100 m
    100m-1 km
    Over 1 km
    p-value*
    N%N%N%
    Sex
     
     
     
     
     
     
    0.000
     Male
    149
    65.6
    418
    58.0
    249
    41.3
     
     Female
    78
    34.4
    303
    42.0
    354
    58.7
     
    Age
     
     
     
     
     
     
    0.000
     Under 19
    7
    3.1
    22
    3.0
    50
    8.3
     
     20~39
    96
    42.3
    351
    43.7
    370
    61.3
     
     40~59
    117
    51.5
    273
    37.9
    162
    26.9
     
     Over 60
    7
    3.1
    75
    10.4
    21
    3.5
     
    Exposure characteristics
     
     
     
     
     
    0.000
     Adjacent residents
    12
    5.4
    126
    17.6
    20
    3.3
     
     Other residents
    12
    5.4
    103
    14.4
    323
    53.7
     
     Workers
    103
    46.6
    408
    56.9
    187
    31.1
     
     Firefighters
    19
    8.6
    1
    0.1
    3
    0.5
     
     Public officials
    9
    4.1
    8
    1.1
    5
    0.8
     
     Others
    66
    29.9
    71
    9.9
    64
    10.6
     
    Time of hospital visit
     
     
     
     
     
    0.000
     Within 3 days
    37
    16.3
    25
    3.5
    8
    1.3
     
     4 days or after
    190
    83.7
    696
    96.5
    595
    98.7
     
    Abnormal physical findings
     
     
     
     
     
     
     Throat
    72/136
    52.9
    273/466
    58.6
    204/400
    51.0
    0.240
     Nose
    10/80
    12.5
    25/248
    10.1
    16/223
    7.2
    0.126
     Eye
    12/82
    14.6
    35/250
    14.0
    25/242
    10.3
    0.202
     Lung
    7/95
    7.4
    8/326
    2.5
    3/303
    1.0
    0.001
     Heart
    0/92
    0.0
    0/294
    0.0
    0/292
    0.0
    -
     Skin
    7/72
    9.7
    15/225
    6.7
    8/229
    3.5
    0.002
    Abnormal PFT
     
     
     
     
     
     
     
     FVC%
    2/14
    14.3
    1/27
    3.7
    1/7
    14.3
    0.739
     FEV1/FVC%0/140.02/277.40/70.00.747
     Under 100 m
    100 m-1 km
    Over 1 km
    p-value *
    N%N%N%
    Sore throat
    51
    22.7
    195
    28.2
    131
    23.5
    0.660
    Headache
    46
    20.4
    142
    20.5
    106
    19.0
    0.549
    Cough
    27
    12.0
    87
    12.6
    82
    14.7
    0.234
    Eye irritation
    21
    9.3
    58
    8.4
    47
    8.4
    0.742
    Shortness of breath
    18
    8.0
    29
    4.2
    19
    3.4
    0.012
    Chest pain
    11
    4.9
    33
    4.8
    18
    3.2
    0.190
    Dizziness
    9
    4.0
    27
    3.9
    17
    3.0
    0.423
    Nausea
    3
    1.3
    26
    3.8
    14
    2.5
    0.784
    Rhinorrhea
    2
    0.9
    13
    1.9
    26
    4.7
    0.001
    Skin burning
    5
    2.2
    13
    1.9
    16
    2.9
    0.405
    Itching
    5
    2.2
    13
    1.9
    9
    1.6
    0.557
    Sputum
    8
    3.6
    7
    1.0
    10
    1.8
    0.289
    Nasal pain
    2
    0.9
    3
    0.4
    9
    1.6
    0.137
    Skin rash
    1
    0.4
    4
    0.6
    0
    0.0
    0.169
    Vomiting
    0
    0.0
    1
    0.1
    0
    0.0
    0.744
    Others
    12
    5.3
    16
    2.3
    20
    3.6
    0.548
    No symptom
    4
    1.8
    25
    3.6
    34
    6.1
    0.003
    Total225100.0692100.0558100.0 
     
    Under 100 m
    100 m-1 km
    Over 1 km
    Crude p-valueAdjusted p-value*
     NMean ± SDNMean ± SDNMean ± SD
    Complete blood cell count
     
     
     
     
     
     
     
     
     WBC (×103/mm3)
    166
    6.97 ± 1.60
    488
    7.11 ± 1.97
    471
    6.99 ± 1.88
    0.548
    0.500
     RBC (×106/mm3)
    166
    4.88 ± 0.46
    488
    4.79 ± 0.48
    471
    4.70 ± 0.46
    0.000
    0.175
     Hemoglobin (g/dL)
    166
    14.8 ± 1.73
    488
    14.7 ± 1.67
    471
    14.0 ± 1.65
    0.000
    0.172
     Hematocrit (%)
    166
    44.1 ± 4.44
    488
    43.5 ± 4.25
    471
    41.9 ± 4.15
    0.000
    0.032
     Platelet (×103/mm3)
    166
    252.8 ± 55.9
    488
    246.8 ± 51.0
    471
    254.6 ± 50.7
    0.057
    0.101
    Serum electrolyte
     
     
     
     
     
     
     
     
     
     
     
     Calcium (mg/dL)
    172
    9.39 ± 0.37
    489
    9.35 ± 0.36
    471
    9.32 ± 0.37
    0.106
    0.226
     Phosphorus (mg/dL)
    172
    3.57 ± 0.58
    489
    3.59 ± 0.57
    471
    3.74 ± 0.63
    0.000
    0.438
     Sodium (mmol/L)
    165
    141.9 ± 1.93
    485
    142.0 ± 2.06
    471
    141.7 ± 1.79
    0.055
    0.611
     Potassium (mmol/L)
    165
    4.13 ± 0.34
    485
    4.07 ± 0.32
    471
    4.04 ± 0.28
    0.006
    0.044
     Chloride (mmol/L)
    164
    102.9 ± 2.04
    485
    103.1 ± 2.03
    471
    103.1 ± 1.84
    0.438
    0.778
    Serum chemistry
     
     
     
     
     
     
     
     
     
     
     
     AST (IU/L)
    162
    24.0 ± 10.8
    476
    25.3 ± 12.4
    470
    23.7 ± 13.5
    0.161
    0.310
     ALT (IU/L)
    162
    25.1 ± 16.6
    476
    26.9 ± 23.7
    470
    23.5 ± 25.1
    0.087
    0.466
     r-GTP§ (IU/L)
    155
    36.8 ± 31.6
    473
    39.3 ± 52.3
    466
    27.5 ± 28.9
    0.000
    0.240
     ALP (IU/L)
    158
    180.6 ± 62.6
    475
    177.6 ± 51.2
    467
    195.8 ± 130.3
    0.010
    0.136
     Glucose (mg/dL)
    156
    113.7 ± 48.5
    461
    105.5 ± 32.9
    446
    100.1 ± 20.9
    0.000
    0.038
     Total cholesterol (mg/dL)
    159
    197.6 ± 36.0
    475
    194.7 ± 36.0
    467
    190.7 ± 35.5
    0.065
    0.816
     Blood urea nitrogen (mg/dL)
    161
    13.9 ± 3.97
    473
    13.1 ± 3.89
    468
    12.7 ± 3.59
    0.001
    0.109
     Creatinine (mg/dL)
    162
    0.88 ± 0.14
    473
    0.89 ± 0.18
    469
    0.81 ± 0.19
    0.000
    0.070
     Uric acid (mg/dL)1525.62 ± 1.494605.51 ± 1.474445.12 ± 1.450.0000.540
    Table 1 Details of the 12 hospitalized patients

    *Hydrogen fluoride, Internal medicine, pulmonology, Internal medicine, gastroenterology, §ENT; Otorhinolaryngology, Neurology, ** Plastric surgery, ++ Gastro-intestinal fiberscopy.

    Table 2 General characteristics of non-hospitalized patients

    Table 3 Chief complaints of early and late patients

    * Early patients: hospital visit within 3 days.

    † Late patients: hospital visit 4 days or after.

    ‡ Chi-squared test.

    Table 4 Symptom complaints of early and late patients

    * Early patients: hospital visit within 3 days.

    † Late patients: hospital visit 4 days or after.

    ‡ Chi-squared test.

    Table 5 Patient characteristics with respect to distance from the accident site

    * Chi-squared test for trend.

    Decreased FVC < 80%.

    Decreased FVC/FEV1 ratio <70%.

    Table 6 Chief complaints with respect to distance from the accident site

    * Chi-squared test for trend.

    Table 7 Laboratory results with respect to distance from the accident site

    *Adjusted for age and sex, using ANCOVA test.

    Aspartate transaminase, Alanine transaminase, §Gamma glutamyl transpeptidase, Alkaline phosphatase.


    Ann Occup Environ Med : Annals of Occupational and Environmental Medicine
    Close layer
    TOP